Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-02-02
1980-04-15
Evans, Joseph E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560 47, A61K 31245, C07C10154
Patent
active
041984315
ABSTRACT:
N-(3-trifluoromethylphenyl)anthranilic acid esters represented by the formula (I): ##STR1## wherein R represents an alkyl group having 4 to 8 carbon atoms, are disclosed.
The esters are useful as anti-inflammatory agents, particularly for an external application, with reduced toxicity. These esters are of great importance as non-steroid type anti-inflammatory agents for topical administration.
REFERENCES:
patent: 3144387 (1964-08-01), Jones
patent: 3413339 (1968-11-01), Scherrer
patent: 3558690 (1971-01-01), Sallmann et al.
patent: 3767811 (1973-10-01), Sherlock
patent: 3855230 (1974-12-01), Water et al.
patent: 4029815 (1977-06-01), Sherlock et al.
patent: 4143151 (1979-03-01), Wagner et al.
Klebanov et al., Chem. Absts., vol. 82, 363p (1975).
Salimbeni et al., Chem. Absts., vol. 83, 274f (1975).
Manghisi et al., Chem. Absts., vol. 77, 114067(x) 1972).
Breitenstein G. T.
Evans Joseph E.
Hokuriku Pharmaceutical Co., Ltd.
Hueschen Gordon W.
LandOfFree
Alkyl N-(3-trifluoromethylphenyl)-anthranilate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl N-(3-trifluoromethylphenyl)-anthranilate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl N-(3-trifluoromethylphenyl)-anthranilate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-476175